POTENSI INHIBITOR α-GLUKOSIDASE EKSTRAK KASAR Streptomyces tendae SEBAGAI PENURUN KADAR GLUKOSA DARAH PADA TIKUS Sprague Dawley DIABETES

Read full text Summarise with VIRAT
Authors: Aliful Karim, Min Rahminiwati, Yulin LESTARI
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Diabetes is a disease caused by insulin dysfunction or impaired insulin production, leading to elevated blood glucose levels (hyperglycemia). It is classified into three types: Type 1, Type 2, and Gestational Diabetes Mellitus (GDM). Type 2 diabetes is a condition resulting from insulin resistance. Previous research has identified microorganisms isolated from Ficus deltoidea that produce α-glucosidase inhibitors. This study aims to determine the potential of extracts derived from Streptomyces tendae as an α-glucosidase inhibitor through both in-vitro and in-vivo assessments, specifically evaluating the extract's effectiveness in reducing blood glucose levels in Sprague Dawley rats with Type 2 diabetes. Although the isolates from previous studies showed a decrease in activity, they remained capable of lowering blood glucose levels in the rats. Statistical analysis of the Oral Glucose Tolerance Test (OGTT) provided sufficient evidence to conclude that the combination of time (minutes) and extract administration significantly influenced the reduction of blood glucose levels in diabetic rats (P

Fields of Study & Subjects

Natural Antidiabetic Agents Studies Pancreatic function and diabetes Diabetes Treatment and Management

Publication details

Journal / source
Jurnal Sumberdaya Hayati
Volume
12
Issue
1
Pages
8–14
Publication date
31 March 2026
Language
EN